[EN] FUSED BICYCLIC PYRAZOLE DERIVATIVES AND METHODS OF USE THEREOF FOR THE TREATMENT OF HERPESVIRUSES<br/>[FR] DÉRIVÉS BICYCLIQUES FUSIONNÉS DE PYRAZOLE ET LEURS MÉTHODES D'UTILISATION POUR LE TRAITEMENT DE VIRUS HERPÉTIQUES
申请人:MERCK SHARP & DOHME
公开号:WO2022132686A1
公开(公告)日:2022-06-23
The present invention relates to novel Fused Bicyclic Pyrazole Derivatives of Formula (I): and pharmaceutically acceptable salts thereof, wherein R1, R2, R3, R4, R5, and R6are as defined herein. The present invention also relates to compositions comprising at least one Fused Bicyclic Pyrazole Derivative, and methods of using the Fused Bicyclic Pyrazole Derivatives for treating or preventing a herpesvirus infection in a patient.
本发明涉及式(I)的新型融合双环吡唑衍生物及其药学上可接受的盐,其中R1、R2、R3、R4、R5和R6如本文所定义。本发明还涉及包含至少一种融合双环吡唑衍生物的组合物,以及使用融合双环吡唑衍生物治疗或预防患者的疱疹病毒感染的方法。